119 related articles for article (PubMed ID: 18433756)
1. Impaired endothelial function in C-reactive protein overexpressing mice.
Teoh H; Quan A; Lovren F; Wang G; Tirgari S; Szmitko PE; Szalai AJ; Ward ME; Verma S
Atherosclerosis; 2008 Dec; 201(2):318-25. PubMed ID: 18433756
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
[TBL] [Abstract][Full Text] [Related]
3. Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.
Kaneko H; Anzai T; Nagai T; Anzai A; Takahashi T; Mano Y; Morimoto K; Maekawa Y; Itoh H; Yoshikawa T; Ogawa S; Fukuda K
Cardiovasc Res; 2011 Aug; 91(3):546-55. PubMed ID: 21447704
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.
Nagai T; Anzai T; Kaneko H; Mano Y; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
Hypertension; 2011 Feb; 57(2):208-15. PubMed ID: 21220701
[TBL] [Abstract][Full Text] [Related]
5. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.
Danenberg HD; Szalai AJ; Swaminathan RV; Peng L; Chen Z; Seifert P; Fay WP; Simon DI; Edelman ER
Circulation; 2003 Aug; 108(5):512-5. PubMed ID: 12874178
[TBL] [Abstract][Full Text] [Related]
6. Role of thromboxane receptor in C-reactive protein-induced thrombosis.
Grad E; Pachino RM; FitzGerald GA; Danenberg HD
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2468-74. PubMed ID: 22879580
[TBL] [Abstract][Full Text] [Related]
7. Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice.
Wang D; Oparil S; Chen YF; McCrory MA; Skibinski GA; Feng W; Szalai AJ
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2094-9. PubMed ID: 16051879
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
9. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice.
Szalai AJ; van Ginkel FW; Dalrymple SA; Murray R; McGhee JR; Volanakis JE
J Immunol; 1998 Jun; 160(11):5294-9. PubMed ID: 9605127
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein promotes vascular endothelial dysfunction partly via activating adipose tissue inflammation in hyperlipidemic rabbits.
Chen Y; Wang X; Mai J; Zhao X; Liang Y; Gu M; Chen Z; Nie R; Wang J
Int J Cardiol; 2013 Oct; 168(3):2397-403. PubMed ID: 23452887
[TBL] [Abstract][Full Text] [Related]
11. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury.
Grad E; Golomb M; Mor-Yosef I; Koroukhov N; Lotan C; Edelman ER; Danenberg HD
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H489-95. PubMed ID: 17369452
[TBL] [Abstract][Full Text] [Related]
13. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
14. Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.
Amiri F; Ko EA; Javeshghani D; Reudelhuber TL; Schiffrin EL
J Hypertens; 2010 Jun; 28(6):1243-51. PubMed ID: 20308920
[TBL] [Abstract][Full Text] [Related]
15. Neointimal formation is reduced after arterial injury in human crp transgenic mice.
Danenberg HD; Grad E; Swaminathan RV; Chen Z; Seifert P; Szalai AJ; Lotan C; Simon DI; Edelman ER
Atherosclerosis; 2008 Nov; 201(1):85-91. PubMed ID: 18358478
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.
Li L; Roumeliotis N; Sawamura T; Renier G
Circ Res; 2004 Oct; 95(9):877-83. PubMed ID: 15472120
[TBL] [Abstract][Full Text] [Related]
17. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.
Kang DH; Park SK; Lee IK; Johnson RJ
J Am Soc Nephrol; 2005 Dec; 16(12):3553-62. PubMed ID: 16251237
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability.
Clapp BR; Hirschfield GM; Storry C; Gallimore JR; Stidwill RP; Singer M; Deanfield JE; MacAllister RJ; Pepys MB; Vallance P; Hingorani AD
Circulation; 2005 Mar; 111(12):1530-6. PubMed ID: 15795363
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice.
Schwartz R; Osborne-Lawrence S; Hahner L; Gibson LL; Gormley AK; Vongpatanasin W; Zhu W; Word RA; Seetharam D; Black S; Samols D; Mineo C; Shaul PW
Circ Res; 2007 May; 100(10):1452-9. PubMed ID: 17446434
[TBL] [Abstract][Full Text] [Related]
20. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
